A Study to Assess Efficacy and Safety of ASP1941 in Diabetic Patients With Renal Impairment

NCT01316094 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

165

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: ASP1941
DRUG: placebo

Sponsor

Astellas Pharma Inc